Patents by Inventor Liat Edry

Liat Edry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8980549
    Abstract: The present invention relates to methods for diagnosing, staging, prognosticating and treating melanoma based on evaluating the expression of specific patterns of oncogenic or suppressive microRNA (miR) molecules in a patient in need thereof.
    Type: Grant
    Filed: August 1, 2011
    Date of Patent: March 17, 2015
    Assignees: Ramot at Tel Aviv University Ltd., Tel Hashomer Medical Research Infrastructure and Services Ltd.
    Inventors: Gal Markel, Eyal Greenberg, Noam Shomron, Liat Edry, Jacob Schachter
  • Publication number: 20140235488
    Abstract: The present invention relates to methods for diagnosing, staging, prognosticating and treating melanoma based on evaluating the expression of specific patterns of oncogenic or suppressive microRNA (miR) molecules in a patient in need thereof.
    Type: Application
    Filed: April 29, 2014
    Publication date: August 21, 2014
    Applicants: TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD., RAMOT AT TEL AVIV UNIVERSITY
    Inventors: Gal Markel, Eyal Greenberg, Noam Shomron, Liat Edry, Jacob Schachter
  • Publication number: 20130197060
    Abstract: The present invention relates to methods for diagnosing, staging, prognosticating and treating melanoma based on evaluating the expression of specific patterns of oncogenic or suppressive microRNA (miR) molecules in a patient in need thereof.
    Type: Application
    Filed: August 1, 2011
    Publication date: August 1, 2013
    Applicants: Tel Hashomer Medical Research Infrastructure and Services Ltd., RAMOT AT TEL AVIV UNIVERSITY
    Inventors: Gal Markel, Eyal Greenberg, Noam Shomron, Liat Edry, Jacob Schachter
  • Publication number: 20130131148
    Abstract: The present invention relates to polymorphic binding sites for micro-RNA and to micro-RNA-based cancer diagnosis, cancer therapy and personalized medicine. In particular, the present invention relates to diagnosis, therapy and personalized medicine with the specific miR-515-5p molecule.
    Type: Application
    Filed: March 10, 2011
    Publication date: May 23, 2013
    Inventors: Noam Shomron, Liat Edry, Efrat Mamluk, Eitan Friedman